The Newshound

More than 20,000 NHS patients with vague symptoms will be offered a new blood test that could detect 13 cancers

An NHS Blood and Transplant unit like those that will support the STRIDE-RCT trial, which aims to determine whether multi-cancer blood tests are reliable enough for broader deployment across the health service.
An NHS Blood and Transplant unit like those that will support the STRIDE-RCT trial, which aims to determine whether multi-cancer blood tests are reliable enough for broader deployment across the health service.

The STRIDE-RCT trial, led by the University of Birmingham and funded by the government, will deploy the new blood tests across around 200 GP surgeries in England. It will focus on patients aged 45 and over presenting with symptoms such as persistent bloating or abdominal pain. Scientists will examine one or two tubes of blood for cancer-signalling proteins or DNA fragments, and may also pinpoint where in the body a tumour has developed. The trial's purpose is to determine whether the tests are sufficiently reliable for broader NHS deployment.

The 13 cancers targeted include pancreatic, ovarian, liver, bowel, stomach, oesophageal, kidney, bladder and prostate cancers.

Around 71,000 people in England are diagnosed with these abdominal cancers each year, and nearly 35,000 die from them.

MoreBBC News'Multi-cancer' blood tests coming to some GP surgeries soonThe TimesGP patients to be offered new blood test for 13 types of cancerHealth and MeBowel, Pancreatic & Liver: NHS Trial Offers New Blood Test To 20,000 Patients That Could Detect 13 Cancers - Health and Memirror.co.ukNHS trials first multi-cancer blood test to investigate common symptoms often dismissed - The Mirrorbbc.co.uk'Multi-cancer' blood tests coming to some GP surgeriesYahoo News UKNHS to trial blood tests that detect multiple cancersTimes NowCan a routine blood test help detect 13 cancers? Here's what the UK NHS is testing
Read today's full feed at The Newshound →